Tag: Chronic Pain Treatment Market Share

Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

Chronic Pain Treatment Market CAGR Outlook And Future Development

The chronic pain treatment market has demonstrated substantial expansion in recent years. This sector is anticipated to increase from $109.05 billion in 2025 to $119.32 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.4%. Historically, this growth has been fueled by factors such as opioid usage, musculoskeletal disorders, an aging population, the establishment of hospital pain clinics, and advancements in post-surgical pain management.

The chronic pain treatment market is projected to experience substantial expansion in the coming years. Its valuation is anticipated to reach $168.99 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.1%. This projected growth during the forecast period is fueled by factors such as opioid regulation, the development of device-based therapies, the rising prevalence of chronic diseases, increased integration of mental health services, and the expansion of outpatient pain care. Significant developments expected over this period encompass a move towards non-opioid pain treatments, the rise of neuromodulation devices, broadening multidisciplinary pain management approaches, a heightened emphasis on individualized pain care, and the incorporation of psychological support strategies.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=59949987&type=smp&name=Chronic%20Pain%20Treatment%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Chronic Pain Treatment Market Demand Drivers Opening New Revenue Streams

The increasing occurrence of arthritis pain is projected to drive the expansion of the chronic pain treatment market in the future. Arthritis pain describes discomfort, aching, or soreness within the joints, resulting from inflammation or degeneration caused by arthritis. The growing prevalence of arthritis pain is primarily influenced by the aging population, as the natural wear and tear on joints intensifies with age, leading to a higher incidence of arthritis-related conditions. Chronic pain treatment aids arthritis pain by targeting inflammation and nerve sensitivity to lessen discomfort, enhance joint function, and improve the overall quality of life for individuals managing persistent arthritis symptoms. For example, in July 2024, the Centers for Disease Control and Prevention, a US-based government agency, reported that an estimated 21.2% of adults aged 18 and older in the US were diagnosed with arthritis in 2023. Therefore, the rising prevalence of arthritis pain is a significant factor propelling the growth of the chronic pain treatment market.

Chronic Pain Treatment Market Segment Landscape: Which Areas Lead Development?

The chronic pain treatment market covered in this report is segmented –

1) By Product Type: Drugs, Devices

2) By Indication: Neuropathic Pain, Arthritis Pain, Chronic Back Pain, Cancer Pain, Migraine, Fibromyalgia, Other Indications

3) By Distribution channels: Direct, Indirect

4) By End-User: Hospitals, Clinics, Nursing Homes, Research Centers And Universities, Other End-Users

Subsegments:

1) By Drugs: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Opioids, Antidepressants, Anticonvulsants, Muscle Relaxants, Topical Analgesics, Other Pain Relief Medications

2) By Devices: Neuromodulation Devices, Transcutaneous Electrical Nerve Stimulation (TENS) Devices, Spinal Cord Stimulators, Peripheral Nerve Stimulators, Radiofrequency Ablation Devices, Implantable Drug Delivery Devices

Chronic Pain Treatment Market Trends Powering Strategic Industry Growth

Major companies operating in the chronic pain treatment market are prioritizing the development of innovative solutions, such as closed-loop spinal cord stimulation (SCS) systems. This focus is driven by the increasing demand for advanced non-opioid therapies, improved long-term pain management, and enhanced patient quality of life. Closed-loop SCS systems are implantable, rechargeable neurostimulators that continuously detect neural signals and automatically modify electrical stimulation in real time, unlike traditional open-loop SCS devices which deliver predetermined and non-responsive output. For instance, in April 2024, Medtronic plc, an Ireland-based medical device company, received U.S. Food and Drug Administration (FDA) approval for the Inceptiv Neurostimulation System. This device is a compact rechargeable implant that uses sensing electrodes to monitor evoked neural responses and automatically adjust stimulation. It provides full-body 1.5T and 3T MRI access with impedance-independent sensing and is indicated for chronic, intractable trunk or limb pain. Its design aims to deliver more consistent pain relief, better responder outcomes, and improved comfort compared with traditional fixed-output SCS systems.

Chronic Pain Treatment Market Industry Leaders And Competitive Landscape

Major companies operating in the chronic pain treatment market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Medtronic plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Boston Scientific Corporation, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC, Mallinckrodt plc, Nevro Corp.

View The Full Chronic Pain Treatment Market Report:

https://thebusinessresearchcompany.com/report/chronic-pain-treatment-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Chronic Pain Treatment Market Global Footprint: Which Region Leads The Industry?

North America was the largest region in the chronic pain treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic pain treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Chronic Pain Treatment Market Growth Potential: How Will Market Size Change Through 2030?

The market for chronic pain treatment has demonstrated substantial expansion over the past few years. Its value is projected to rise from $109.05 billion in 2025 to $119.32 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.4%. This historical growth has been driven by several factors, including the utilization of opioids, the prevalence of musculoskeletal disorders, an increasingly aged population, the establishment of hospital-based pain clinics, and the management of pain following surgical procedures.

The chronic pain treatment market is projected to experience significant expansion in the coming years, with a forecasted value of $168.99 billion by 2030, reflecting a compound annual growth rate (CAGR) of 9.1%. This anticipated growth during the forecast period is driven by factors such as opioid regulation, the adoption of device-based therapies, the rising prevalence of chronic diseases, the integration of mental health treatments, and the expansion of outpatient pain care services. Key trends shaping this period include a notable shift towards non-opioid pain management approaches, the increasing use of neuromodulation devices, the broader adoption of multidisciplinary pain management strategies, a stronger emphasis on personalized treatment plans, and the incorporation of psychological support into pain care regimens.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24504&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

#Chronic Pain Treatment Market Growth Factors: Which Forces Are Supporting Market Expansion?

The increasing occurrence of arthritis pain is anticipated to boost the chronic pain treatment market in the coming period. Arthritis pain involves joint discomfort, ache, or tenderness resulting from inflammation or deterioration linked to arthritis. This rising trend is largely attributed to an aging population, where natural joint wear and tear grows with advancing age, elevating the likelihood of arthritis-related conditions. Chronic pain management assists with arthritis pain by mitigating inflammation and nerve hypersensitivity, thereby alleviating discomfort, improving joint mobility, and enhancing the overall well-being of those enduring persistent arthritis symptoms. As an example, in July 2024, the Centers for Disease Control and Prevention, a US government entity, reported that around 21.2% of adults aged 18 and older in the United States had been diagnosed with arthritis in 2023. Consequently, the growing prevalence of arthritis pain is fueling expansion in the chronic pain treatment market.

Chronic Pain Treatment Market Segment Outlook: Which Categories Are Expanding The Fastest?

The chronic pain treatment market covered in this report is segmented –

1) By Product Type: Drugs, Devices

2) By Indication: Neuropathic Pain, Arthritis Pain, Chronic Back Pain, Cancer Pain, Migraine, Fibromyalgia, Other Indications

3) By Distribution channels: Direct, Indirect

4) By End-User: Hospitals, Clinics, Nursing Homes, Research Centers And Universities, Other End-Users

Subsegments:

1) By Drugs: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Opioids, Antidepressants, Anticonvulsants, Muscle Relaxants, Topical Analgesics, Other Pain Relief Medications

2) By Devices: Neuromodulation Devices, Transcutaneous Electrical Nerve Stimulation (TENS) Devices, Spinal Cord Stimulators, Peripheral Nerve Stimulators, Radiofrequency Ablation Devices, Implantable Drug Delivery Devices

Chronic Pain Treatment Market Industry Trends: What Changes Are Reshaping Demand?

In the chronic pain treatment market, major players are prioritizing the creation of advanced solutions like closed-loop spinal cord stimulation (SCS) systems to address the growing need for non-opioid alternatives that offer superior long-term pain management and enhanced patient well-being. These closed-loop systems are implantable, rechargeable neurostimulators that continuously detect neural activity and dynamically adjust electrical stimulation in real time, setting them apart from conventional open-loop SCS devices that rely on fixed, unresponsive settings. A notable example is Medtronic plc, an Irish medical device company, which secured U.S. Food and Drug Administration (FDA) approval in April 2024 for its Inceptiv Neurostimulation System. This compact, rechargeable implant utilizes sensing electrodes to monitor evoked neural responses and fine-tune stimulation automatically, offering full-body compatibility with 1.5T and 3T MRI scans through impedance-independent sensing. It is indicated for managing chronic, persistent pain in the trunk or limbs and is engineered to deliver more consistent relief, superior responder outcomes, and greater comfort compared to standard fixed-output SCS systems.

Chronic Pain Treatment Market Key Companies And Competitive Benchmarking

Major companies operating in the chronic pain treatment market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Medtronic plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Boston Scientific Corporation, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC, Mallinckrodt plc, Nevro Corp.

Access The Complete Chronic Pain Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/chronic-pain-treatment-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Chronic Pain Treatment Market Regional Outlook: Where Are The Largest Opportunities Located?

North America was the largest region in the chronic pain treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic pain treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Forecasted Rise In Market Size Of The Chronic Pain Treatment Market During The Forecast Period?

The chronic pain treatment market has experienced robust growth in recent years. This market is projected to expand from $109.05 billion in 2025 to $119.32 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.4%. Historically, this growth can be attributed to factors such as opioid usage, musculoskeletal disorders, an aging population, the proliferation of hospital pain clinics, and advancements in post-surgical pain management.

The chronic pain treatment market is anticipated to experience substantial expansion in the coming years. Its valuation is projected to reach $168.99 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.1%. This expansion during the forecast period is primarily driven by factors such as stricter opioid regulation, the adoption of device-based therapies, the increasing prevalence of chronic diseases, greater integration of mental health services, and the rise of outpatient pain care. Significant trends foreseen for this period include a move towards non-opioid pain treatments, the increasing use of neuromodulation devices, the broader implementation of multidisciplinary pain management approaches, a heightened emphasis on personalized pain care, and the incorporation of psychological support therapies.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24504&type=smp

What Market Drivers Are Helping Shape The Chronic Pain Treatment Market Expansion?

The increasing occurrence of arthritis-related pain is anticipated to drive the expansion of the chronic pain treatment market in the future. Arthritis pain is characterized by discomfort, aches, or tenderness in the joints resulting from inflammation or degeneration associated with arthritis. This growing prevalence of arthritis pain primarily stems from the aging demographic, given that the natural wear and tear on joints intensifies with age, contributing to a higher incidence of arthritis-related conditions. Chronic pain treatment addresses arthritis pain by focusing on reducing inflammation and nerve sensitivity, thereby alleviating discomfort, enhancing joint mobility, and improving the general quality of life for those experiencing ongoing arthritis symptoms. For example, data from July 2024, provided by the Centers for Disease Control and Prevention, a US-based government body, indicated that approximately 21.2% of adults aged 18 and older in the US had received an arthritis diagnosis in 2023. Consequently, the increasing prevalence of arthritis pain is propelling the expansion of the chronic pain treatment market.

How Is The Chronic Pain Treatment Market Distributed Across Key Segments?

The chronic pain treatment market covered in this report is segmented –

1) By Product Type: Drugs, Devices

2) By Indication: Neuropathic Pain, Arthritis Pain, Chronic Back Pain, Cancer Pain, Migraine, Fibromyalgia, Other Indications

3) By Distribution channels: Direct, Indirect

4) By End-User: Hospitals, Clinics, Nursing Homes, Research Centers And Universities, Other End-Users

Subsegments:

1) By Drugs: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Opioids, Antidepressants, Anticonvulsants, Muscle Relaxants, Topical Analgesics, Other Pain Relief Medications

2) By Devices: Neuromodulation Devices, Transcutaneous Electrical Nerve Stimulation (TENS) Devices, Spinal Cord Stimulators, Peripheral Nerve Stimulators, Radiofrequency Ablation Devices, Implantable Drug Delivery Devices

Which Trends Are Influencing The Direction Of The Chronic Pain Treatment Market?

Leading companies active in the chronic pain treatment market are prioritizing the development of innovative solutions, such as closed-loop spinal cord stimulation (SCS) systems, to address the growing demand for advanced non-opioid therapies, superior long-term pain management, and an improved quality of life for patients. These closed-loop SCS systems are implantable, rechargeable neurostimulators that continually sense neural signals and autonomously adjust electrical stimulation in real time, unlike traditional open-loop SCS devices that deliver a fixed, non-responsive output. For example, in April 2024, Medtronic plc, an Ireland-based medical device manufacturer, obtained U.S. Food and Drug Administration (FDA) approval for its Inceptiv Neurostimulation System. This device is a compact, rechargeable implant that utilizes sensing electrodes to observe evoked neural responses and automatically fine-tune stimulation. It supports full-body 1.5T and 3T MRI access with impedance-independent sensing and is indicated for chronic, intractable trunk or limb pain, engineered to provide more consistent pain relief, better responder outcomes, and enhanced comfort compared to conventional fixed-output SCS systems.

Which Companies Form The Competitive Landscape Of The Chronic Pain Treatment Market?

Major companies operating in the chronic pain treatment market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Medtronic plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Boston Scientific Corporation, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC, Mallinckrodt plc, Nevro Corp.

Access The Complete Chronic Pain Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/chronic-pain-treatment-global-market-report

Which Region Contributes The Most To The Chronic Pain Treatment Market?

North America was the largest region in the chronic pain treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic pain treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Chronic Pain Treatment Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=24504&type=smp

Browse Through More Reports Similar to the Global Chronic Pain Treatment Market 2026, By The Business Research Company

Chronic Pain Market Report 2026

https://www.thebusinessresearchcompany.com/report/chronic-pain-global-market-report

Pain Management Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/pain-management-drugs-global-market-report

Cold Pain Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/cold-pain-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Expansion In Market Value Is Forecasted For The Chronic Pain Treatment Market Between 2026 And 2030?

The chronic pain treatment market size has experienced substantial expansion in recent years. It is anticipated to increase from $109.05 billion in 2025 to $119.32 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.4%. Historically, this growth can be ascribed to factors such as opioid usage, musculoskeletal disorders, an aging population, the presence of hospital pain clinics, and post-surgical pain management.

The chronic pain treatment market size is anticipated to experience significant expansion in the coming years, projected to reach $168.99 billion by 2030, growing at a compound annual growth rate (CAGR) of 9.1%. This projected growth during the forecast period is attributable to factors such as opioid regulation, the development of device-based therapies, the rising prevalence of chronic diseases, increased mental health integration, and the expansion of outpatient pain care. Noteworthy trends for the forecast period include a shift towards non-opioid pain therapies, the increasing adoption of neuromodulation devices, the broadening of multidisciplinary pain management strategies, a greater emphasis on personalized pain care, and the integration of psychological support therapies.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24504&type=smp

What Key Factors Are Shaping The Chronic Pain Treatment Market Landscape?

The increasing occurrence of arthritis pain is anticipated to drive the expansion of the chronic pain treatment market in the future. Arthritis pain describes the unease, throbbing, or tenderness experienced in joints, resulting from inflammation or deterioration linked to arthritis. The growing incidence of arthritis pain is largely fueled by the older demographic, given that natural joint wear and tear escalates with age, contributing to a higher occurrence of arthritis-related issues. Chronic pain treatment addresses arthritis pain by focusing on inflammation and nerve sensitivity, aiming to lessen discomfort, enhance joint mobility, and elevate the overall quality of life for those experiencing ongoing arthritis symptoms. As an illustration, in July 2024, data from the Centers for Disease Control and Prevention, a US-based government body, indicated that approximately 21.2% of adults aged 18 and above in the US had received an arthritis diagnosis in 2023. Consequently, the increasing prevalence of arthritis pain is a significant factor in the growth of the chronic pain treatment market.

What Are The Key Segment Divisions In The Chronic Pain Treatment Market Segment Structure?

The chronic pain treatment market covered in this report is segmented –

1) By Product Type: Drugs, Devices

2) By Indication: Neuropathic Pain, Arthritis Pain, Chronic Back Pain, Cancer Pain, Migraine, Fibromyalgia, Other Indications

3) By Distribution channels: Direct, Indirect

4) By End-User: Hospitals, Clinics, Nursing Homes, Research Centers And Universities, Other End-Users

Subsegments:

1) By Drugs: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Opioids, Antidepressants, Anticonvulsants, Muscle Relaxants, Topical Analgesics, Other Pain Relief Medications

2) By Devices: Neuromodulation Devices, Transcutaneous Electrical Nerve Stimulation (TENS) Devices, Spinal Cord Stimulators, Peripheral Nerve Stimulators, Radiofrequency Ablation Devices, Implantable Drug Delivery Devices

What Trends Are Affecting The Direction Of The Chronic Pain Treatment Market?

Major companies within the chronic pain treatment market are concentrating on developing innovative solutions, such as closed-loop spinal cord stimulation (SCS) systems, to address the increasing demand for advanced non-opioid therapies, improved long-term pain control, and enhanced patient quality of life. Closed-loop SCS systems are implantable, rechargeable neurostimulators designed to continuously monitor neural signals and automatically adjust electrical stimulation in real time, unlike traditional open-loop SCS devices that deliver predetermined and non-responsive output. For instance, in April 2024, Medtronic plc, an Ireland-based medical device company, received U.S. Food and Drug Administration (FDA) approval for the Inceptiv Neurostimulation System. This device is a compact, rechargeable implant that utilizes sensing electrodes to observe evoked neural responses and automatically regulate stimulation. It offers full-body 1.5T and 3T MRI access with impedance-independent sensing and is indicated for chronic, intractable trunk or limb pain. The system is engineered to provide more consistent pain relief, better responder outcomes, and improved comfort compared to conventional fixed-output SCS systems.

Which Organizations Are Engaged In The Chronic Pain Treatment Market?

Major companies operating in the chronic pain treatment market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Medtronic plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Boston Scientific Corporation, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC, Mallinckrodt plc, Nevro Corp.

Get The Full Chronic Pain Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/chronic-pain-treatment-global-market-report

Which Region Accounts For The Largest Portion Of The Chronic Pain Treatment Market?

North America was the largest region in the chronic pain treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic pain treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Chronic Pain Treatment Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/chronic-pain-treatment-global-market-report

Browse Through More Reports Similar to the Global Chronic Pain Treatment Market 2026, By The Business Research Company

Chronic Pain Market Report 2026

https://www.thebusinessresearchcompany.com/report/chronic-pain-global-market-report

Pain Management Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/pain-management-drugs-global-market-report

Cold Pain Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/cold-pain-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Expected For The Chronic Pain Treatment Market At The End Of The 2026–2030 Forecast Period?

The chronic pain treatment market has experienced robust growth in recent years. This market is projected to expand from $109.05 billion in 2025 to reach $119.32 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.4%. Factors contributing to its historical expansion include opioid usage, musculoskeletal disorders, an aging population, the presence of hospital pain clinics, and effective post-surgical pain management.

The chronic pain treatment market size is anticipated to undergo significant expansion over the next few years. It is projected to reach $168.99 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.1%. This projected growth can be attributed to factors such as opioid regulation, the emergence of device-based therapies, the increasing prevalence of chronic diseases, the integration of mental health services, and the rise of outpatient pain care. Key trends for the forecast period include a shift towards non-opioid pain therapies, the expansion of neuromodulation devices, a broadening of multidisciplinary pain management approaches, an increased emphasis on personalized pain care, and the incorporation of psychological support therapies.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24504&type=smp

What Primary Drivers Are Shaping The Development Of The Chronic Pain Treatment Market?

The escalating occurrence of arthritis pain is projected to drive the expansion of the chronic pain treatment market. Arthritis pain describes the discomfort, aching, or tenderness experienced in the joints due to inflammation or degeneration caused by arthritis. The increasing prevalence of arthritis pain primarily stems from the aging demographic, as natural wear and tear on joints intensifies with age, contributing to a higher incidence of arthritis-related conditions. Chronic pain treatment aids in managing arthritis pain by targeting inflammation and nerve sensitivity, which helps to alleviate discomfort, enhance joint function, and boost the overall quality of life for individuals grappling with persistent arthritis symptoms. For instance, in July 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, an estimated 21.2% of adults aged 18 and older in the US were diagnosed with arthritis in 2023. Therefore, the rising prevalence of arthritis pain is propelling the growth of the chronic pain treatment market.

What Segment Types Make Up The Chronic Pain Treatment Market?

The chronic pain treatment market covered in this report is segmented –

1) By Product Type: Drugs, Devices

2) By Indication: Neuropathic Pain, Arthritis Pain, Chronic Back Pain, Cancer Pain, Migraine, Fibromyalgia, Other Indications

3) By Distribution channels: Direct, Indirect

4) By End-User: Hospitals, Clinics, Nursing Homes, Research Centers And Universities, Other End-Users

Subsegments:

1) By Drugs: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Opioids, Antidepressants, Anticonvulsants, Muscle Relaxants, Topical Analgesics, Other Pain Relief Medications

2) By Devices: Neuromodulation Devices, Transcutaneous Electrical Nerve Stimulation (TENS) Devices, Spinal Cord Stimulators, Peripheral Nerve Stimulators, Radiofrequency Ablation Devices, Implantable Drug Delivery Devices

Which Market Trends Are Creating New Opportunities In The Chronic Pain Treatment Market?

Leading companies in the chronic pain treatment market are concentrating on developing innovative solutions, such as closed-loop spinal cord stimulation (SCS) systems. This focus aims to address the increasing demand for advanced non-opioid therapies, superior long-term pain management, and an improved quality of life for patients. Closed-loop SCS systems are implantable, rechargeable neurostimulators that continuously detect neural signals and automatically modify electrical stimulation in real time, unlike conventional open-loop SCS devices that deliver preset and non-responsive output. For example, in April 2024, Medtronic plc, an Ireland-based medical device company, obtained U.S. Food and Drug Administration (FDA) approval for its Inceptiv Neurostimulation System. This device is a compact, rechargeable implant that utilizes sensing electrodes to monitor evoked neural responses and automatically adjust stimulation. It provides full-body 1.5T and 3T MRI access with impedance-independent sensing and is indicated for chronic, intractable trunk or limb pain. The system is engineered to offer more consistent pain relief, better responder outcomes, and enhanced comfort compared to traditional fixed-output SCS systems.

Who Are The Key Players Driving Competition In The Chronic Pain Treatment Market?

Major companies operating in the chronic pain treatment market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Medtronic plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Boston Scientific Corporation, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC, Mallinckrodt plc, Nevro Corp.

Read the full chronic pain treatment market report here:

https://www.thebusinessresearchcompany.com/report/chronic-pain-treatment-global-market-report

How Does The Chronic Pain Treatment Market Perform Across Major Global Regions?

North America was the largest region in the chronic pain treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic pain treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Chronic Pain Treatment Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24504&type=smp

Browse Through More Reports Similar to the Global Chronic Pain Treatment Market 2026, By The Business Research Company

Chronic Pain Market Report 2026

https://www.thebusinessresearchcompany.com/report/chronic-pain-global-market-report

Pain Management Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/pain-management-drugs-global-market-report

Cold Pain Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/cold-pain-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the chronic pain treatment market from 2026–2035 with trusted insights from The Business Research Company

What total market size is anticipated for the Chronic Pain Treatment Market in 2030?

The chronic pain treatment market size has experienced significant expansion in recent years. Looking ahead, this market is projected to expand from $109.05 billion in 2025 to $119.32 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 9.4%. Factors such as opioid usage, musculoskeletal disorders, an aging population, the presence of hospital pain clinics, and advancements in post-surgical pain management are identified as contributors to its historical growth.

The chronic pain treatment market size is anticipated to experience substantial expansion in the coming years. It is projected to reach $168.99 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.1%. This growth throughout the forecast period can be ascribed to factors such as opioid regulation, device-based therapies, the prevalence of chronic diseases, integration of mental health services, and the expansion of outpatient pain care. Key trends expected during the forecast period encompass a movement towards non-opioid pain treatments, the rise of neuromodulation devices, broader multidisciplinary pain management, heightened emphasis on personalized pain care, and the incorporation of psychological support therapies.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24504&type=smp

What Drivers Are Influencing Production Trends In The Chronic Pain Treatment Market?

The increasing occurrence of arthritis pain is anticipated to fuel the expansion of the chronic pain treatment market in the foreseeable future. Arthritis pain describes the discomfort, aching, or tenderness experienced in joints, resulting from inflammation or degeneration caused by arthritis. The increasing incidence of arthritis pain is mainly attributed to the growing elderly population, as the natural wear and tear of joints intensifies with age, contributing to a higher number of arthritis-related conditions. Chronic pain treatment aids in alleviating arthritis pain by addressing inflammation and nerve sensitivity, thereby reducing discomfort, improving joint mobility, and enhancing the overall well-being for those with ongoing arthritis symptoms. For example, in July 2024, data from the Centers for Disease Control and Prevention, a government agency based in the US, indicated that approximately 21.2% of adults aged 18 and older in the US had received an arthritis diagnosis in 2023. Consequently, the growing prevalence of arthritis pain is a significant factor propelling the growth of the chronic pain treatment market.

Which Segments Are Gaining Traction In The Chronic Pain Treatment Market?

The chronic pain treatment market covered in this report is segmented –

1) By Product Type: Drugs, Devices

2) By Indication: Neuropathic Pain, Arthritis Pain, Chronic Back Pain, Cancer Pain, Migraine, Fibromyalgia, Other Indications

3) By Distribution channels: Direct, Indirect

4) By End-User: Hospitals, Clinics, Nursing Homes, Research Centers And Universities, Other End-Users

Subsegments:

1) By Drugs: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Opioids, Antidepressants, Anticonvulsants, Muscle Relaxants, Topical Analgesics, Other Pain Relief Medications

2) By Devices: Neuromodulation Devices, Transcutaneous Electrical Nerve Stimulation (TENS) Devices, Spinal Cord Stimulators, Peripheral Nerve Stimulators, Radiofrequency Ablation Devices, Implantable Drug Delivery Devices

What Industry Trends Are Transforming The Chronic Pain Treatment Market?

Leading companies in the chronic pain treatment market are concentrating on developing advanced solutions, such such as closed-loop spinal cord stimulation (SCS) systems. This effort aims to address the growing demand for innovative non-opioid treatments, more effective long-term pain management, and an enhanced quality of life for patients. Unlike conventional open-loop SCS devices which provide fixed and unresponsive output, closed-loop SCS systems are implantable, rechargeable neurostimulators designed to continuously detect neural signals and dynamically modify electrical stimulation in real time. An example of this advancement is Medtronic plc, an Ireland-based medical device company, which secured U.S. Food and Drug Administration (FDA) approval in April 2024 for its Inceptiv Neurostimulation System. This system is a compact, rechargeable implant that employs sensing electrodes to observe evoked neural responses and automatically tailor stimulation. It offers full-body 1.5T and 3T MRI access with impedance-independent sensing and is specifically indicated for chronic, intractable trunk or limb pain. The design of the Inceptiv system targets more stable pain relief, superior patient outcomes, and greater comfort when contrasted with older fixed-output SCS systems.

Who Are The Major Companies Operating In The Chronic Pain Treatment Market?

Major companies operating in the chronic pain treatment market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Medtronic plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Boston Scientific Corporation, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC, Mallinckrodt plc, Nevro Corp.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/chronic-pain-treatment-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Chronic Pain Treatment Market?

North America was the largest region in the chronic pain treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic pain treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Chronic Pain Treatment Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24504&type=smp

Browse Through More Reports Similar to the Global Chronic Pain Treatment Market 2026, By The Business Research Company

Chronic Pain Market Report 2026

https://www.thebusinessresearchcompany.com/report/chronic-pain-global-market-report

Pain Management Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/pain-management-drugs-global-market-report

Cold Pain Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/cold-pain-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Larger Is The Chronic Pain Treatment Market Expected To Become By 2029 Compared With Its 2025 Level?

The chronic pain treatment market size has demonstrated substantial expansion in recent years. This market is expected to increase from $99.64 billion in 2024 to $109.05 billion in 2025, reflecting a compound annual growth rate (CAGR) of 9.4%. During prior periods, this growth was primarily influenced by an aging population, a rising incidence of chronic diseases, enhanced awareness concerning pain management, an increase in the use of prescription opioids, and broader health insurance coverage.

The chronic pain treatment market is projected to experience substantial expansion in the coming years. This market is set to reach $155 billion by 2029, expanding at a compound annual growth rate (CAGR) of 9.2%. This anticipated growth during the forecast period is driven by factors such as a move towards non-opioid alternatives, greater government funding for pain research, an increasing demand for personalized medicine, the growing adoption of digital pain management tools, and the expanded application of AI for pain diagnosis and treatment planning. Key trends anticipated within the forecast timeframe encompass advancements in neuromodulation therapies, the integration of telemedicine into pain care, the development of cannabinoid-based therapies, an emphasis on multidisciplinary treatment approaches, and an increase in wearable pain monitoring devices.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24504&type=smp

What Are The Key Drivers Of Growth In The Chronic Pain Treatment Market?

An anticipated increase in arthritis pain is projected to fuel the expansion of the chronic pain treatment market in the future. Arthritis pain is defined as the unpleasant sensation, throbbing, or tenderness experienced in joints, resulting from inflammation or deterioration stemming from arthritis. This increasing occurrence of arthritis pain is predominantly fueled by an aging demographic, given that the natural wear and tear on joints escalates with age, culminating in a higher frequency of conditions linked to arthritis. Treatment for chronic pain addresses arthritis pain by focusing on reducing inflammation and nerve sensitivity, thereby alleviating discomfort, enhancing joint mobility, and elevating the overall quality of life for those experiencing ongoing arthritis symptoms. As an illustration, data from March 2023, provided by the Office for Health Improvement and Disparities, a UK-based government entity, indicated that in 2022, 17.6% of persons aged 16 and older reported experiencing a long-term musculoskeletal (MSK) condition, including arthritis or continuous issues with their back or joints; this figure shows a rise from 17.0% recorded in 2021. Consequently, the growing incidence of arthritis pain is stimulating the expansion of the chronic pain treatment market.

Which Key Segments Fueling The Chronic Pain Treatment Market?

The chronic pain treatment market covered in this report is segmented –

1) By Product Type: Drugs, Devices

2) By Indication: Neuropathic Pain, Arthritis Pain, Chronic Back Pain, Cancer Pain, Migraine, Fibromyalgia, Other Indications

3) By Distribution channels: Direct, Indirect

4) By End-User: Hospitals, Clinics, Nursing Homes, Research Centers And Universities, Other End-Users

Subsegments:

1) By Drugs: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Opioids, Antidepressants, Anticonvulsants, Muscle Relaxants, Topical Analgesics, Other Pain Relief Medications

2) By Devices: Neuromodulation Devices, Transcutaneous Electrical Nerve Stimulation (TENS) Devices, Spinal Cord Stimulators, Peripheral Nerve Stimulators, Radiofrequency Ablation Devices, Implantable Drug Delivery Devices

What Trends Are Redefining The Chronic Pain Treatment Market Dynamics?

Key players in the chronic pain treatment market are concentrating on creating cutting-edge products like rechargeable spinal cord stimulators to increase patient convenience and optimize long-term pain management results. A rechargeable spinal cord stimulator is a medical apparatus surgically placed near the spine that emits electrical pulses to inhibit pain signals, and it can be replenished externally without needing an operation. It assists in managing chronic pain by disrupting the pain pathways within the spinal cord, thereby lowering the perception of pain for patients suffering from conditions such as failed back surgery syndrome or neuropathic pain. As an illustration, in December 2022, Abbott Laboratories, a US-based medical device company, unveiled the Eterna spinal cord stimulation system. Being more compact than an Apple AirPods case, the Eterna device is exceptionally small and inconspicuous, presenting a user-friendly answer for addressing chronic pain. It delivers considerable pain alleviation, has shown the capacity to lessen reliance on opioid medications, and is engineered for extended, minimally invasive deployment, consequently boosting patients’ daily functionality and their overall quality of life.

Which Global Market Leaders Are Shaping The Future Of The Chronic Pain Treatment Sector?

Major companies operating in the chronic pain treatment market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Medtronic plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Boston Scientific Corporation, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC, Mallinckrodt plc, Nevro Corp.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/chronic-pain-treatment-global-market-report

What Regional Growth Trends Are Shaping The Chronic Pain Treatment Market Outlook?

North America was the largest region in the chronic pain treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic pain treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Chronic Pain Treatment Market Report:

https://www.thebusinessresearchcompany.com/customise?id=24504&type=smp

Browse Through More Reports Similar to the Global Chronic Pain Treatment Market 2025, By The Business Research Company

Chronic Pain Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/chronic-pain-global-market-report

Pain Management Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pain-management-drugs-global-market-report

Cold Pain Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cold-pain-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Estimated Industry Valuation for the Chronic Pain Treatment Sector?

In the past few years, the chronic pain treatment market has experienced significant growth. The market value is projected to increase from $99.64 billion in 2024 to $109.05 billion in 2025, signifying a compound annual growth rate (CAGR) of 9.4%. Factors contributing to the growth in this period include an aging population, increased occurrence of chronic diseases, a heightened understanding of pain management, the widespread use of prescription opioids, and the broadening of health insurance coverage.

The market size for chronic pain treatment is anticipated to experience robust expansion in the coming years, with an estimated growth to reach $155 billion by 2029, showcasing a compound annual growth rate (CAGR) of 9.2%. The predicted growth during the forecasted period can be associated with an inclination towards non-opioid alternatives, heightened government investment in pain research, mounting demand for personalized medicine, increased uptake of digital tools for pain management, and the evolving implementation of Artificial Intelligence in diagnosing and planning pain treatment. Significant trends during the forecast period comprise progress in neuromodulation therapies, incorporation of telemedicine into pain care, the advent of cannabinoid-based therapies, emphasis on multidisciplinary treatment strategies, and the surge in wearable devices for pain monitoring.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24504&type=smp

What Forces Are Driving The Growth Of The Chronic Pain Treatment Market?

The increasing instances of arthritis pain are set to drive the growth of the chronic pain treatment market in the future. This discomfort in the joints due to inflammation or degeneration from arthritis is what is referred to as arthritis pain. The increase in arthritis pain is mainly attributed to an aging population because the likelihood of experiencing joint wear and tear elevates naturally with age, leading to a higher occurrence of arthritis-related conditions. To alleviate arthritis pain, chronic pain treatment focuses on inflammation and nerve sensitivity, which lessens discomfort, improves joint function, and boosts the overall quality of life for those struggling with constant arthritis symptoms. For example, the Office for Health Improvement and Disparities, a UK-based government department, reported that in March 2023, in the previous year, 17.6% of people aged 16 and over revealed that they had a long-term musculoskeletal (MSK) ailment, such as arthritis or enduring back or joint problems, exhibiting an increase from 17.0% in 2021. Consequently, the increasing instances of arthritis pain are fueling the expansion of the chronic pain treatment market.

How Is The Chronic Pain Treatment Industry Segmented Across Key Parameters?

The chronic pain treatment market covered in this report is segmented –

1) By Product Type: Drugs, Devices

2) By Indication: Neuropathic Pain, Arthritis Pain, Chronic Back Pain, Cancer Pain, Migraine, Fibromyalgia, Other Indications

3) By Distribution channels: Direct, Indirect

4) By End-User: Hospitals, Clinics, Nursing Homes, Research Centers And Universities, Other End-Users

Subsegments:

1) By Drugs: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Opioids, Antidepressants, Anticonvulsants, Muscle Relaxants, Topical Analgesics, Other Pain Relief Medications

2) By Devices: Neuromodulation Devices, Transcutaneous Electrical Nerve Stimulation (TENS) Devices, Spinal Cord Stimulators, Peripheral Nerve Stimulators, Radiofrequency Ablation Devices, Implantable Drug Delivery Devices

What Notable Trends Are Shaping The Direction Of The Chronic Pain Treatment Market?

In the chronic pain treatment market, prominent businesses are prioritizing the innovation of sophisticated products like rechargeable spinal cord stimulators to heighten patient comfort and optimize lasting pain management results. A rechargeable spinal cord stimulator, which is a medical device placed close to the spine to emit electric pulses that obstruct pain signs, can be replenished externally without requiring surgery. It serves to control chronic pain by breaking off pain routes in the spinal cord and lowers pain perception in individuals with conditions like failed back surgery syndrome or neuropathic pain. For instance, Abbott Laboratories, a medical device firm from the US, introduced the Eterna spinal cord stimulation system in December 2022. The Eterna unit, smaller than an Apple AirPods case, is extremely neat and unobtrusive, providing a user-friendly solution for treating chronic pain. It offers significant pain relief, shown potential for decreasing dependence on opioid medications and is created for long-term, minimally intrusive use, ultimately improving daily operations and patients’ overall life quality.

Which Companies Currently Dominate The Competitive Landscape In The Chronic Pain Treatment Industry?

Major companies operating in the chronic pain treatment market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Medtronic plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Boston Scientific Corporation, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC, Mallinckrodt plc, Nevro Corp.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/chronic-pain-treatment-global-market-report

Which Geographic Regions Are Driving Demand In The Chronic Pain Treatment Market?

North America was the largest region in the chronic pain treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic pain treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=24504&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Chronic Pain Treatment Market Grown from 2024 to 2025?

Recent years have seen significant expansion in the chronic pain treatment market size. Predicted growth from $99.64 billion in 2024 to $109.05 billion in 2025, with a compound annual growth rate (CAGR) of 9.4%, indicates a strong market trend. Factors like an aging demographic, the increasing incidence of chronic conditions, heightened awareness about pain management, an increase in prescribed opioid usage, and broadening health insurance coverage contribute to this historical growth.

What Growth Rate Is Anticipated for the Chronic Pain Treatment Market in the Coming Years?

In the coming years, the market size for chronic pain treatment is set to witness significant growth, increasing to $155 billion in 2029 at a CAGR of 9.2%. This projected growth during the forecast period can be credited to the shift towards non-opioid alternatives, increase in government funding dedicated to pain research, the rising demand for tailored medicinal solutions, a growing trend in the utilization of digital tools for pain management, and enhanced usage of AI in diagnosing and planning pain treatment. The estimate period also highlights several emerging trends including improvements in the field of neuromodulation therapies, the incorporation of telemedicine in providing pain care, the development of treatments based on cannabinoids, emphasis on multidisciplinary treatment strategies, and the growth of wearable devices for monitoring pain.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24504&type=smp

Who Are the Leading Companies in the Chronic Pain Treatment Market?

Major companies operating in the chronic pain treatment market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Medtronic plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Boston Scientific Corporation, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC, Mallinckrodt plc, Nevro Corp.

What Are the Key Drivers of the Chronic Pain Treatment Market?

Anticipated to fuel the expansion of the chronic pain treatment market, is the growing frequency of arthritis pain. Arthritis pain refers to joint discomfort, ache, or soreness due to inflammation or degeneration from arthritis. The increasing occurrence of this kind of pain is mainly due to an aging population, as natural joint degeneration and wear that comes with age lead to a higher incidence of arthritis-related conditions. By targeting nerve sensitivity and inflammation, chronic pain treatment aids in reducing discomfort caused by arthritis, improving joint function, and enhancing the overall living standard for individuals contending with persistent arthritis symptoms. For instance, per the UK’s Office for Health Improvement and Disparities, in 2023, in 2022, a long-term musculoskeletal (MSK) condition such as arthritis or persistent issues with their back or joints was reported by 17.6% of individuals 16 years and older. This shows an increase from the 17.0% reported in 2021. Hence, the growing incidence of arthritis pain contributes to the expansion of the chronic pain treatment market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=24504&type=smp

What Are the Key Market Segments in the Chronic Pain Treatment Industry?

The chronic pain treatment market covered in this report is segmented –

1) By Product Type: Drugs, Devices

2) By Indication: Neuropathic Pain, Arthritis Pain, Chronic Back Pain, Cancer Pain, Migraine, Fibromyalgia, Other Indications

3) By Distribution channels: Direct, Indirect

4) By End-User: Hospitals, Clinics, Nursing Homes, Research Centers And Universities, Other End-Users

Subsegments:

1) By Drugs: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Opioids, Antidepressants, Anticonvulsants, Muscle Relaxants, Topical Analgesics, Other Pain Relief Medications

2) By Devices: Neuromodulation Devices, Transcutaneous Electrical Nerve Stimulation (TENS) Devices, Spinal Cord Stimulators, Peripheral Nerve Stimulators, Radiofrequency Ablation Devices, Implantable Drug Delivery Devices

What Are the Latest Trends in the Chronic Pain Treatment Market?

Focusing on the development of innovative products like rechargeable spinal cord stimulators is the main strategy of leading companies in the chronic pain treatment market to help improve patient convenience and optimise long-term pain management results. This medical device, that can be implanted near the spine, generates electrical pulses to nullify pain signals and can be externally recharged without the need for surgery. It is used to control chronic pain by inhibiting pain pathways in the spinal cord, lessening the pain experienced by people with conditions like failed back surgery syndrome or neuropathic pain. For instance, in December 2022, the Eterna spinal cord stimulation system was introduced by Abbott Laboratories, a medical device company based in the US. With a size smaller than an Apple AirPods case, Eterna is highly compact, discreet, and patient-friendly for managing chronic pain. Besides providing significant pain relief, it has shown potential in lowering dependency on opioid drugs and is designed for long-term and minimally invasive use, thereby improving patients’ overall daily functioning and quality of life.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/chronic-pain-treatment-global-market-report

What Are the Key Regional Markets in the Chronic Pain Treatment Industry?

North America was the largest region in the chronic pain treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic pain treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24504

This Report Delivers Insight On:

1. How big is the chronic pain treatment market, and how is it changing globally?

2. Who are the major companies in the chronic pain treatment market, and how are they performing?

3. What are the key opportunities and risks in the chronic pain treatment market right now?

4. Which products or customer segments are growing the most in the chronic pain treatment market?

5. What factors are helping or slowing down the growth of the chronic pain treatment market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model